MedTrace Logo

Modeling DNA Diversity in Cardiovascular Health/Disease

NCT00005490 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-11-07

No results posted yet for this study

Summary

To identify and measure DNA sequence variation in 13 genes that play a central role in key physiological functions involved in the development of cardiovascular disease, that is, genes involved in lipid metabolism, carbohydrate metabolism, and blood pressure regulation.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Deborah Nickerson · University of Washington

  • Charles Sing · University of Michigan

  • Kenneth Weiss · Penn State University

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-08-31
Completion
2003-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005490 on ClinicalTrials.gov